Authors

• Jeffrey Leflein
• Kirsten P. Perrett (ORCID: https://orcid.org/0000-0002-5683-996X)
• Benjamin Ortiz (ORCID: https://orcid.org/0000-0001-6950-5582)
• Aurélie Gautier
• Kari Christine Nadeau (ORCID: https://orcid.org/0000-0002-2146-2955)
• Joseph L. Roberts (ORCID: https://orcid.org/0000-0001-6839-1173)
• A. Muraro
• Motoi Hosoe (ORCID: https://orcid.org/0000-0001-6848-3713)
• Rima A Rachid
• Wei Qiang Wang (ORCID: https://orcid.org/0000-0002-1430-1360)
• Philippe Bégin
• Iván Bottoli
• Gideon Lack
• Matthew Greenhawt
• Motohiro Ebisawa
• Munir Winkel
• Aikaterini Anagnostou
• Eva Schlosser

Institutions

• Novartis (Switzerland) (CH)
• Boston Children's Hospital (US)
• Royal Children's Hospital (AU)
• Harvard University (US)
• University of Padua (IT)
• Emory University (US)
• Asthma and Allergy Foundation of America (US)
• Centre Hospitalier Universitaire Sainte-Justine (CA)
• Novartis (China) (CN)
• National Sagamihara Hospital (JP)
• Ann Arbor Center for Independent Living (US)
• Texas Children's Hospital (US)
• Novartis Institutes for BioMedical Research
• London School of Economics and Political Science (GB)

Publication Details

Journal

Allergy

Published

2026-01-20

DOI

https://doi.org/10.1111/all.70206

Primary Topic

Food Allergy and Anaphylaxis Research

Type

article

Field-Weighted Citation Impact

0.00

Funders

• AstraZeneca
• Sanofi
• Food Allergy Research and Education
• Regeneron Pharmaceuticals
• Immune Tolerance Network
• Aimmune Therapeutics
• Allergy Therapeutics
• Federal Agency for Science and Innovation
• National Institutes of Health
• Genentech
• Novartis Pharma
• Medical Research Council
• National Health and Medical Research Council
• National Heart, Lung, and Blood Institute
• National Institute of Allergy and Infectious Diseases
• National Institute of Environmental Health Sciences